BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 05:00 pm
Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window ....
Gennex Laboratories Ltd · 531739
✦ AI Summary
Gennex Laboratories Ltd has announced the closure of its trading window for insiders from July 01, 2026, until 48 hours after the public announcement of its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The date for the Board Meeting to approve these results will be intimated in due course.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gennex Laboratories Ltd - 531739 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
f151e2ec-6033-4293-bc44-767ac86e72e9.pdf
View document text
te —-s
G GENNEX
Ref: GLL/BSE /2026-27 /Jun - Date: June 23, 2026
To To
The General Manager, The Listing Manager,
Corporate Relations Department, The Ahmedabad Stock Exchange Limited
BSE Limited A-2, Kamdhenu Complex, Opp. Sahajanand
Phiroze Jeejeebhoy Towers, College, 120 Feet Ring Road, Panjara Pol,
Dalal Street, Mumbai - 400001. Ambawadi, Ahmedabad - 380015.
Maharashtra State, India. Gujarat State, India.
Script Code: 531739 Script Code:
The Calcutta Stock Exchange Limited,
#7, Lyons Range, Murgighata,
Dalhousie, Kolkata - '700001,
West Bengal State, India.
Scrip Code: 26178
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
Ref: BSE Security ID: GENNEX, Script Code: 531739 & 890171
Notice is hereby given that in pursuance of SEBI (Prohibition of Insider Trading)
Regulations, 2015 and Company's Code of Conduct for Regulating, Monitoring and
Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the
Company shall remain closed from July 01, 2026 till 48 hours after the public
announcement through Board of Directors in their Meeting held for announcing the Un-
audited Standalone and Consolidated Financial Results for the First Quarter ended on June
30, 2026 along with other matters for which trading window is required to be closed.
The Board Meeting date to approve the Un-audited Standalone and Consolidated financial
results of the Company for the First Quarter ending on June 30, 2026 will be informed in
due course.
All Promoters/designated/connected persons are advised not to trade in the securities of
the Company either directly or indirectly during the aforesaid period of Closure of Trading
Window.
We request you to take the above information on record and acknowledge the receipt of the
same.
Thanking you,
Yours faithfully
For Gennex Laboratories Limited
Digitally signed by
DINESH KR DINESH KR KEJRIWAL
Date: 2026.06.23
KEJRIWAL 14:51:57 +05'30"
Dinesh Kumar Kejriwal
Company Secretary & Compliance Officer
M. No.-A/19293
Gennex Laboratories Limited
Office: ‘Akash Ganga’ 4" Floor, Plot NO.144, Srinagar colony, Hyderabad-500073, T.S. India | Phone: +91-40-67334400 (30 Lines), Fax: +91-40-67334433
Factory: Sy.No.133, IDA Bollaram, Jinnaram Mandal, Sangareddy Dist — 502325, Telangana, India | Tel: +91-08458 279406, Telefax: +91-08454 279516
Info(@gennexlab.com, www.gennexlab.com i CIN :L24230TG1990PLC011168